News

Apretude is a long-acting injectable medication used for HIV pre-exposure prophylaxis (PrEP). Planned Parenthood will offer ...
The Trump administration has lifted a freeze on federal funds for HIV prevention and surveillance programs, officials said, ...
The Centers for Disease Control and Prevention (CDC) reinstated more than 400 employees who had previously been laid off, the ...
In a sweeping national overhaul of HIV prevention funding, the CDC chose to bypass local and statewide community ...
The CDC has withdrawn $200,000 in annual HIV prevention funding from AVOL Kentucky, a community-based nonprofit. This decision, part of a national funding overhaul, shifts resources away from ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The Trump administration eliminated the CDC team that developed national guidelines for prescribing contraception safely for ...
In the heart of Chicago’s Lakeview neighborhood, the work to shore up healthcare carries on at Howard Brown Health. “We are a ...
Congressional leaders celebrated the restored $20 million in previously frozen HIV prevention funds and surveillance programs ...
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...
The state and local health departments that rely on CDC funding say the money is not coming in on time and no one can tell ...
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be HIV-negative to get it.